ChiCTR2400085182 版本V1.0 版本创建时间2024/06/03 09:40:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400085182 

最近更新日期:

Date of Last Refreshed on:

2024-06-03 09:40:14 

注册时间:

Date of Registration:

2024-06-03 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

关于改良单孔腹腔镜胆囊切除术对比传统单孔腹腔镜胆囊切除术的前瞻性随机双盲临床研究

Public title:

Prospective randomized double-blind clinical study of modified single-hole laparoscopic cholecystectomy versus conventional single-hole laparoscopic cholecystectomy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

关于改良单孔腹腔镜胆囊切除术对比传统单孔腹腔镜胆囊切除术的前瞻性随机双盲临床研究

Scientific title:

Prospective randomized double-blind clinical study of modified single-hole laparoscopic cholecystectomy versus conventional single-hole laparoscopic cholecystectomy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

周正 

研究负责人:

周正 

Applicant:

Zheng Zhou 

Study leader:

Zheng Zhou 

申请注册联系人电话:

Applicant telephone:

+86 138 2843 4680

研究负责人电话:

Study leader's telephone:

+86 138 2843 4680

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhouzh76@mail.sysu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

zhouzh76@mail.sysu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省深圳市福田区深南中路3025号

研究负责人通讯地址:

广东省深圳市福田区深南中路3025号

Applicant address:

NO.3025 Shennan Middle Road, Futian District, Shenzhen City, Guangdong Province, China

Study leader's address:

NO.3025 Shennan Middle Road, Futian District, Shenzhen City, Guangdong Province, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中山大学附属第八医院(深圳福田)

Applicant's institution:

The Eighth Affiliated Hospital, Sun Yat-sen University

研究负责人所在单位:

中山大学附属第八医院(深圳福田)

Affiliation of the Leader:

The Eighth Affiliated Hospital, Sun Yat-sen University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

中大附八科研伦理2023-035-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中山大学附属第八医院(深圳福田)医学科研伦理委员会

Name of the ethic committee:

IRB of The Eighth Affiliated Hospital, SunYat-Sen University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-07-25 00:00:00

伦理委员会联系人:

苏翠林

Contact Name of the ethic committee:

Cuilin Su

伦理委员会联系地址:

广东省深圳市福田区深南中路3025号

Contact Address of the ethic committee:

No. 3025 Shennan Middle Road, Futian District, Shenzhen City, Guangdong Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 158 1736 0312

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中山大学附属第八医院(深圳福田)

Primary sponsor:

The Eighth Affiliated Hospital, Sun Yat-sen University

研究实施负责(组长)单位地址:

广东省深圳市福田区深南中路3025号

Primary sponsor's address:

No. 3025, Shennan Middle Road, Futian Street, Futian District, Shenzhen City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

深圳市

Country:

China

Province:

Guangdong

City:

Shenzhen

单位(医院):

中山大学附属第八医院(深圳福田)

具体地址:

广东省深圳市福田区深南中路3025号

Institution
hospital:

The Eighth Affiliated Hospital, Sun Yat-sen University

Address:

No. 3025 Shennan Middle Road, Futian District, Shenzhen City, Guangdong Province

经费或物资来源:

福田区卫生健康局

Source(s) of funding:

Futian District Health Bureau

Target disease:

Gallbladder disease

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

通过前瞻性研究较两种单孔腹腔镜胆囊切除方式,旨在探索伤口疤痕更小、更微创、安全,更易于术者操作的单孔腹腔镜手术方式。  

Objectives of Study:

Compared with the two methods of single hole laparoscopic cholecystectomy, the prospective study aims to explore the single hole laparoscopic surgery which is smaller, more minimally invasive, safer and easier to operate.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1)术前两种或以上影像学诊断胆囊结石伴慢性胆囊炎、急性胆囊炎、胆囊息肉、胆囊腺肌症等胆囊良性疾病;2)签署知情同意书同意入组该临床试验者。

Inclusion criteria

1) Preoperative diagnosis of gallstones with chronic cholecystitis, acute cholecystitis, gallbladder polyps, gallbladder adenomyosis and other benign gallbladder diseases by two or more imaging methods; 2) Signed informed consent to be enrolled in the clinical trial.

排除标准:

1)既往腹部手术病史,2)术前影像学未除外胆囊恶性肿瘤患者,3)术后病理证实胆囊恶性肿瘤者,4)术中中转为传统三孔法腹腔镜胆囊切除术5)拒绝入组临床研究者。

Exclusion criteria:

1) Previous history of abdominal surgery, 2) patients with gallbladder malignancy not excluded by preoperative imaging, 3) patients with gallbladder malignancy confirmed by postoperative pathology, 4) patients who switched to traditional three-hole laparoscopic cholecystectomy during the operation, 5) clinical investigators were refused to be enrolled.

研究实施时间:

Study execute time:

From 2024-05-01 00:00:00 To 2025-06-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-05 00:00:00 To 2024-10-31 00:00:00  

干预措施:

Interventions:

组别:

实验组

样本量:

55

Group:

Experimental group

Sample size:

干预措施:

实验组行改良单孔腹腔镜胆囊切除术

干预措施代码:

Intervention:

Experimental group underwent conventional single-hole laparoscopic cholecystectomy

Intervention code:

组别:

对照组

样本量:

55

Group:

control group

Sample size:

干预措施:

对照组行传统单孔腹腔镜胆囊切除术

干预措施代码:

Intervention:

Control group underwent modified single-hole laparoscopic cholecystectomy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

深圳 

Country:

China 

Province:

Guangdong 

City:

Shenzhen 

单位(医院):

中山大学附属第八医院(深圳福田) 

单位级别:

三甲 

Institution
hospital:

The Eighth Affiliated Hospital, Sun Yat-sen University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后括术后 12 周的体像评分及伤口疤痕评价

指标类型:

主要指标

Outcome:

The postoperative results included body image score and scar evaluation at 12 weeks after surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中出血量

指标类型:

次要指标

Outcome:

Intraoperative blood loss

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术时间

指标类型:

次要指标

Outcome:

Operation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中转传统三孔腹腔镜病例/总病例数

指标类型:

次要指标

Outcome:

Cases of conversion to traditional three-hole laparoscopy/total cases

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中安全性关键术野的完成率

指标类型:

次要指标

Outcome:

The completion rate of safety-critical surgical fields during the operation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

外科医生的评价

指标类型:

次要指标

Outcome:

The surgeon's assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

伤口满意度评分

指标类型:

次要指标

Outcome:

Wound satisfaction score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

胆囊

组织:

Sample Name:

gallbladder

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

通过随机数表随机分配实验组与对照组

Randomization Procedure (please state who generates the random number sequence and by what method):

The experimental group and the control group were randomly assigned by a random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

实施干预措施后对受试者、研究者设盲,研究者与患者均不了解分组方式,麻醉后手术开始前进行随机分组,术后无论何种手术方式,均只使用单一辅料贴附脐部伤口。

Blinding:

After the intervention, subjects and investigators were blinded, and neither the investigators nor the patients knew the grouping method. After anesthesia, randomized groups were performed before the operation began. After surgery, only a single excipient was applied to the umbilical cord wound regardless of the surgical method.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例报告表;电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-06-03 09:40:14